ArticleFrontiers in dental medicine2026
Effect of glycaemic control on growth factor release and
Article in Frontiers in dental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Platelet-rich fibrin has shown regenerative potential in periodontal treatments; nonetheless, patients with Type 2 diabetes mellitus (T2DM) may experience altered biological activities. Therefore, this study aimed to evaluate the regenerative potential and growth factor release profiles of advanced platelet-rich fibrin (A PRF) and injectable platelet-rich fibrin (i-PRF) derived from participants with controlled and uncontrolled T2DM. Methods: This study compared Results: PRF derived from participants with uncontrolled T2DM demonstrated significantly reduced PDGF-BB and TGF- Conclusions: A-PRF and i-PRF derived from participants with well-controlled T2DM exhibited biological properties comparable to those of healthy non-diabetic individuals, whereas uncontrolled T2DM was associated with reduced release of key growth factors, indicating compromised healing potential. These findings suggest that achieving good glycaemic control may optimize the biological performance of PRF for periodontal regenerative therapy. However, the present findings are based on
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.